Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 10, 2026, 12:41 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1081–1104 of 1,281 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Infection Prophylaxis Clear all

Conditions: Acquired Immunodeficiency Syndrome, Stress Disorders, Post-Traumatic
Interventions: Questionnaires; Behavioral
Lead sponsor: Stanford University; Other
Eligibility: 15 Years to 25 Years
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2011
U.S. locations: 1
States / cities: Stanford, California

Conditions: HIV/AIDS
Interventions: Waitlist, Intervention; Behavioral
Lead sponsor: Florida International University; Other
Eligibility: 18 Years and older
Enrollment: 84 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021
U.S. locations: 1
States / cities: Miami, Florida

Conditions: Surgical Wound Infection
Interventions: Prevena Incision Management System, Conventional sterile dry wound dressing; Device · Other
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years to 100 Years
Enrollment: 1,869 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2018
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Skin Infection
Interventions: Medicinal honey, Bacitracin; Drug
Lead sponsor: Henry Ford Health System; Other
Eligibility: 18 Years to 100 Years
Enrollment: 17 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: Novi, Michigan

Conditions: Malaria
Interventions: P. falciparum infection, Chloroquine, Primaquine; Biological · Drug
Lead sponsor: Seattle Children's Hospital; Other
Eligibility: 18 Years to 50 Years
Enrollment: 36 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2012
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Human Immunodeficiency Virus
Interventions: Dapivirine; Drug
Lead sponsor: International Partnership for Microbicides, Inc.; Industry
Eligibility: 18 Years to 60 Years · Female only
Enrollment: 16 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2018
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Clostridioides Difficile Infection
Interventions: Ursodiol 500 MG; Drug
Lead sponsor: Medical College of Wisconsin; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Milwaukee, Wisconsin

Conditions: Allergy, Seasonal Allergic Rhinitis, Perennial Allergic Rhinitis
Interventions: Not listed
Lead sponsor: West Penn Allegheny Health System; Other
Eligibility: 6 Years to 18 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2009
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Pediatric Burns
Interventions: Culturelle, Placebo; Dietary Supplement
Lead sponsor: Shriners Hospitals for Children; Other
Eligibility: 6 Months to 18 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2015
U.S. locations: 1
States / cities: Cincinnati, Ohio

Conditions: Hiv, Opioid Use Disorder
Interventions: community-friendly health recovery program, Pre-Exposure Prophylaxis and Post-Exposure Prophylaxis; Behavioral · Drug
Lead sponsor: University of Connecticut; Other
Eligibility: 18 Years and older
Enrollment: 256 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Antibiotic Side Effect, Eyelid; Wound, Eyelid Diseases, Surgical Wound Infection, Surgical Wound, Recent, Surgical Incision, Skin Cancer Face, Antibiotic Allergy, Surgical Site Infection
Interventions: Topical Antibiotic Product, Topical Non-Antibiotic Ointment; Drug
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years and older
Enrollment: 401 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Malaria
Interventions: VRC-MALMAB0114-00-AB, Plasmodium falciparum (P. falciparum) sporozoite challenge; Drug · Other
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: 18 Years to 50 Years
Enrollment: 32 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: HIV Infections
Interventions: Face-to-face training, Distance training, Popular Opinion Leader (POL); Behavioral
Lead sponsor: Medical College of Wisconsin; Other
Eligibility: 18 Years and older
Enrollment: 99 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2019
U.S. locations: 1
States / cities: Milwaukee, Wisconsin

Conditions: HIV
Interventions: Truvada, Gel lubricant; Drug · Device
Lead sponsor: Emory University; Other
Eligibility: 18 Years to 49 Years · Male only
Enrollment: 86 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2017
U.S. locations: 1
States / cities: Decatur, Georgia

Conditions: Upper Respiratory Tract Infections
Interventions: Echinacea purpurea product, Placebo; Biological
Lead sponsor: University of Washington; Other
Eligibility: 21 Years to 65 Years
Enrollment: 67 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2011
U.S. locations: 1
States / cities: Kenmore, Washington

Conditions: Ebola Virus Disease, Marburg Virus Disease
Interventions: cAd3-Marburg, cAd3-EBO-S; Biological
Lead sponsor: Albert B. Sabin Vaccine Institute; Other
Eligibility: 18 Years to 50 Years
Enrollment: 32 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021
U.S. locations: 1
States / cities: Oklahoma City, Oklahoma

Conditions: HIV Infections, Sexually Transmitted Diseases, Pregnancy
Interventions: Full Parent communication intervention, Brief Parent Communication Intervention, Control Parent Intervention; Behavioral
Lead sponsor: Centers for Disease Control and Prevention; Federal
Eligibility: 9 Years to 12 Years
Enrollment: 2,210 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 1999 – 2006
U.S. locations: 3
States / cities: Little Rock, Arkansas • Athens, Georgia • Atlanta, Georgia

Conditions: Prevention of Zika Infection, Zika-Specific Immune Response
Interventions: VRC-ZKADNA085-00-VP; Biological
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: 18 Years to 35 Years
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2019
U.S. locations: 3
States / cities: Decatur, Georgia • Baltimore, Maryland • Bethesda, Maryland

Conditions: Recurrent C. Difficile Infection
Interventions: CP101, Placebo; Biological · Other
Lead sponsor: Finch Research and Development LLC.; Industry
Eligibility: 18 Years and older
Enrollment: 19 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 61
States / cities: Phoenix, Arizona • Mission Hills, California • Oakland, California + 51 more

Conditions: Urinary Tract Infections, Catheter-Related Infections
Interventions: methenamine hippurate, Ciprofloxacin; Drug
Lead sponsor: University of Pennsylvania; Other
Eligibility: 18 Years and older · Female only
Enrollment: 201 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2020
U.S. locations: 4
States / cities: Philadelphia, Pennsylvania

Conditions: Health Personnel Attitude, Health Knowledge, Attitudes, Practice
Interventions: Tailored HPV Education and Professional Skills Intervention Group, General HPV Education and Communication Skills Control Group; Behavioral
Lead sponsor: University of Texas, El Paso; Other
Eligibility: 18 Years to 65 Years
Enrollment: 161 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2024
U.S. locations: 2
States / cities: Las Cruces, New Mexico • El Paso, Texas

Conditions: COVID-19
Interventions: Hydroxychloroquine (HCQ); Drug
Lead sponsor: NYU Langone Health; Other
Eligibility: 18 Years and older
Enrollment: 130 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020
U.S. locations: 1
States / cities: New York, New York

Conditions: Staphylococcal Infections, Methicillin-resistant Staphylococcus Aureus
Interventions: Daptomycin, Vancomycin; Drug
Lead sponsor: Mountain Home Research & Education Corporation; Other
Eligibility: 18 Years to 90 Years
Enrollment: 28 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2014
U.S. locations: 2
States / cities: Johnson City, Tennessee • Mountain Home, Tennessee

Conditions: Infection; Cesarean Section, Surgical Wound Infection, Endometritis
Interventions: 80% inhaled oxygen via non-rebreather mask, 30% inhaled oxygen via nasal cannula; Other
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 12 Years to 50 Years · Female only
Enrollment: 606 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2010
U.S. locations: 1
States / cities: St Louis, Missouri

Search by objective public record fields.

HIV Prevention and Care of Psychological Trauma in Vulnerable Rwandan Youth

Acceptability, Feasibility and Preliminary Impact of OurPlan, an mHealth HIV Prevention Intervention for Male Couples

Negative Pressure Wound Therapy for Prevention of Poststernotomy Infection

The Use of Medical Grade Honey in the Prevention of Bone Anchored Hearing Aid Associated Skin Breakdown

Malaria Challenge in Healthy Volunteers

Pharmacokinetic Study of the Dapivirine Vaginal Ring in Lactating Women

Prevention of Recurrence of Clostridioides Difficile Colitis With Ursodeoxycholic Acid (UCDA) as a Supplement to Standard Therapy

Pilot Study of Allergy Immunotherapy and Prevention of Viral Respiratory Infections

Study of Culturelle in the Prophylaxis of Infection and Diarrhea

Optimizing Evidence-based HIV Prevention Targeting People Who Inject Drugs on PrEP

Topical Antibiotic Prophylaxis for Eyelids

Trial to Evaluate L9LS in Healthy Adults

Effectiveness of Communication Technology in Disseminating HIV Prevention Training to Non-governmental Organizations

PrEP, Lube, and the Rectal Mucosa in MSM at Risk of HIV

Three Arm Trial of Immune Effects of Echinacea

Evaluation of Safety, Tolerability and Immune Responses of Ebola-S and Marburg Vaccines in Healthy Adults

Parents Matter!: Interventions to Promote Effective Parent-Child Communication

Safety and Immunogenicity of a Zika Virus DNA Vaccine, VRC-ZKADNA085-00-VP, in Healthy Adults

A Trial of CP101 for the Prevention of Recurrent CDI (PRISM4)

Short-course Methenamine Hippurate for Prevention of Post-operative UTI

Healthcare Provider Human Papillomavirus Education and Professional Skills Intervention

COVID-19 PrEP HCW HCQ Study

Daptomycin Use for Antimicrobial Prophylaxis in Methicillin Resistant Staphylococcus Aureus (MRSA) Colonized Adult Patients Undergoing Primary Elective Hip, Knee, or Shoulder Arthroplasty

Controlled Clinical Trial of Supplemental Oxygen for the Prevention of Post-Cesarean Infectious Morbidity